Abstract
Adult kidney transplant (KT) recipients with SARS-CoV-2 infection are susceptible to a more serious COVID-19 disease compared to immunocompetent patients, including more severe pneumonia, longer duration of illness and worse patient prognosis. Moreover, a high risk of allograft damage, possibly leading to allograft loss, has been reported. In contrast, data regarding the clinical course of infected pediatric KT recipients are scarce. Herein, we describe the clinical features, management and outcome of 2 deceased-donor KT pediatric recipients with SARS-CoV-2 infection, occurred during early and late post-transplant period.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
